Trimethoprim, Sulfamethoxazole Drug Combination
"Trimethoprim, Sulfamethoxazole Drug Combination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS.
| Descriptor ID |
D015662
|
| MeSH Number(s) |
D02.065.884.725.867.500 D02.092.146.807.867.500 D02.886.590.700.725.867.500 D03.383.742.906.500 D26.310.875
|
| Concept/Terms |
Trimethoprim, Sulfamethoxazole Drug Combination- Trimethoprim, Sulfamethoxazole Drug Combination
- Centrin
- Cotrimoxazole
- Eslectin
- Insozalin
- TMP-SMX
- Trimethoprim-Sulfamethoxazole
- Trimethoprim Sulfamethoxazole
- Sulfamethoxazole-Trimethoprim Combination
- Sulfamethoxazole Trimethoprim Combination
- Trimethoprim-Sulfamethoxazole Combination
- Trimethoprim Sulfamethoxazole Combination
- Trimezole
- Co-Trimoxazole
- Co Trimoxazole
- TMP SMX
- Centran
- Trimedin
|
Below are MeSH descriptors whose meaning is more general than "Trimethoprim, Sulfamethoxazole Drug Combination".
Below are MeSH descriptors whose meaning is more specific than "Trimethoprim, Sulfamethoxazole Drug Combination".
This graph shows the total number of publications written about "Trimethoprim, Sulfamethoxazole Drug Combination" by people in this website by year, and whether "Trimethoprim, Sulfamethoxazole Drug Combination" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 1 | 2 |
| 2017 | 1 | 0 | 1 |
| 2019 | 0 | 2 | 2 |
| 2021 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Trimethoprim, Sulfamethoxazole Drug Combination" by people in Profiles.
-
Antimicrobial Susceptibility of Elizabethkingia Species: Report from a Reference Laboratory. J Clin Microbiol. 2022 06 15; 60(6):e0254121.
-
Alterations of human skin microbiome and expansion of antimicrobial resistance after systemic antibiotics. Sci Transl Med. 2021 12 22; 13(625):eabd8077.
-
Kidney stone formation and the gut microbiome are altered by antibiotics in genetic hypercalciuric stone-forming rats. Urolithiasis. 2021 Jun; 49(3):185-193.
-
N-acetyltransferase 2 enzyme genotype-phenotype discordances in both HIV-negative and HIV-positive Nigerians. Pharmacogenet Genomics. 2019 07; 29(5):106-113.
-
A decade of antimicrobial resistance in Staphylococcus aureus: A single center experience. PLoS One. 2019; 14(2):e0212029.
-
A Placebo-Controlled Trial of Antibiotics for Smaller Skin Abscesses. N Engl J Med. 2017 06 29; 376(26):2545-2555.
-
Impact of Staphylococcus aureus USA300 Colonization and Skin Infections on Systemic Immune Responses in Humans. J Immunol. 2016 08 15; 197(4):1118-26.
-
The complex relationship between CD4 count, HIV viral load, trimethoprim-sulfamethoxazole prophylaxis, and skin-and-soft-tissue infection risk in patients with HIV: insights from a causal diagram and simulation study. Epidemiol Infect. 2016 10; 144(13):2889-98.
-
Recurrent skin and soft tissue infections in HIV-infected patients during a 5-year period: incidence and risk factors in a retrospective cohort study. BMC Infect Dis. 2015 Oct 26; 15:455.
-
Antibacterial Treatment for Uncomplicated Skin Infections. N Engl J Med. 2015 06 18; 372(25):2460.